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The secretion of endocrine hormones from pituitary cells finely regulates a multitude of homeo-
static processes. To dynamically adapt to changing physiological status and environmental stimuli,
the pituitary gland must undergo marked structural and functional plasticity. Endocrine cell plas-
ticity is thought to primarily rely on variations in cell proliferation and size. However, cell motility,
a process commonly observed in a variety of tissues during development, may represent an addi-
tional mechanism to promote plasticity within the adult pituitary gland. To investigate this, we
used multiphoton time-lapse imaging methods, GH-enhanced green fluorescent protein trans-
genic mice and sexual dimorphism of the GH axis as a model of divergent tissue demand. Using
thesemethods to acutely (12 h) track cell dynamics, we report that ovariectomy induces a dramatic
and dynamic increase in cell motility, which is associated with gross GH-cell network remodeling.
These changes can be prevented by estradiol supplementation and are associated with enhanced
network connectivity as evidenced by increased coordinated GH-cell activity during multicellular
calcium recordings. Furthermore, cell motility appears to be sex-specific, because reciprocal alter-
ations are not detected in males after castration. Therefore, GH-cell motility appears to play an
important role in the structural and functional pituitary plasticity, which is evoked in response to
changing estradiol concentrations in the female. (Endocrinology 152: 4789–4799, 2011)
The pulsatile secretion of endocrine hormones from thepituitary gland is essential for the regulation of many
important body processes, such as growth and metabo-
lism, reproduction, and stress responses. To maintain ho-
meostasis, endocrine cell activity must dynamically adapt
to changing physiological status and environmental con-
ditions. A key aspect of this functional adaptation is the
ability of pituitary cell populations to undergo marked
plasticity in response to demand, generating the appro-
priate tissue output in the form of hormone. It is widely
acknowledged that alterations in cell number (i.e. hypo- or
hyperplasia) (1, 2) and cell size (i.e. hypo- or hypertrophy)
(3) represent the principal mechanisms underlying pitu-
itary plasticity. However, due to the historic lack of tech-
niqueswithwhich tomonitor and track cell kinetics in situ
in real time, the potential contribution of cell motility to
structural and functional plasticitywithin themammalian
pituitary gland remains to be determined.
Recently, we have shown that the pituitary gland con-
tributes to sex differences in GH secretion through the
effects of gonadal steroids directly upon GH-cell function
and output (4). The arrangement of GH-cells into a three-
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dimensional GH-cell network that wires the gland allows
coordinated propagation of information between distant
cell ensembles after arrival of the hypothalamic secreta-
gogueGHRH (4–6). Gonadal steroids target this GH-cell
network, altering correlated cell activity and secretory
output in response to GHRH (4). Although the mecha-
nisms underlying this functional divergence are elusive, it
may be partly due to remodeling of GH-cell network con-
nectivity by gonadal steroids, because sex differences in
GH-cell topological organization are observedduring sex-
ual maturation (4, 5).
In other tissues, such as the developing and adult brain,
gonadal steroids are able to induce a range of permanent
morphological changes that are important for behavioral
and functional differences between the sexes. For exam-
ple, estradiol induces neurite extension and influences
synaptic density in a number of brain regions, perinatal
exposure to the same sex steroid potently increases den-
dritic spine number in neurons comprising the hippocam-
pus, ventromedial, and mediobasal hypothalamus, and
brain structure dynamically changes as a function of stage
of themenstrual cycle (seeRefs. 7–10 and reviewed inRef.
11). Interestingly, the permissive effects of gonadal ste-
roids on carcinoma invasiveness are, in part, due to the
promotion of motility in transformed cells. Indeed, exog-
enous application of estradiol has been shown to potently
increase motility in both estrogen receptor (ER)-positive
mammaryand endometrial cells (12, 13).Despite thewell-
defined role of gonadal steroids in driving pituitary plas-
ticity in response to both physiological and pathological
demands in adults (2, 14–18), it remains to be shown
whether they can impact cell motility to induce structural
remodeling and sexually differentiated function of endo-
crine cell populations such as GH-cells.
We therefore investigated the motility of living pitu-
itary cells and whether sexually dimorphic GH-cell net-
work function in adults was associated with differential
effects of gonadal steroids on GH-cell motility and struc-
tural rearrangement. To facilitate this, we took advantage
of a tractable GH-cell model [GH-enhanced green fluo-
rescent protein (eGFP)] (19), allowing us to dynamically
image and track single-cell movement over a 12-h period.
By subjecting acute pituitary slices derived from intact and
gonadectomized GH-eGFP animals to multiphoton time-
lapse imaging (12 h), we here report a role for cell motility
in structural and functional pituitary plasticity.
Materials and Methods
Animals
Mice expressing GH-eGFP under the control of the human
GH promoter were used in all experiments as previously de-
scribed (19). Unless otherwise stated, all animals were postpu-
bertal adults between 60 and 80 d old. Three groups of animals
were used: sham, gonadectomized, and gonadectomized hor-
mone replacement [ethinylestradiol (EE), 0.03 mg pellet; Inno-
vative Research of America, Sarasota, FL]. For gonadectomy
experiments, mice were anesthetized by an ip injection of a ket-
amine (Merial, Lyon, France) (1%)/xylazine (Bayer, Leverkusen,
Germany) (0.1%) mixture. In all cases, experiments were per-
formed 6 d after surgery, a period of time shown to coincidewith
gross structural remodeling events after gonadectomy or hor-
mone treatment (2, 20). To control for confounding effects of
gonadal steroids on other estrogen-sensitive pituitary cell pop-
ulations, such as lactotrophs, slices taken from mice expressing
rat PRL-promoter driven DsRed were also imaged (21, 22). All
animal studies were conducted in compliance with the animal
welfare guidelines of the European Community and/or the
United Kingdom Home Office, as appropriate.
Live imaging and cell motility analysis
Thickpituitary slices (200m)wereprepared fromGH-eGFP
animals as previously described (5). Slices were immediately
transferred to a custom made incubation chamber (37 C,
95%O2/5%CO2), which was mounted on the microscope stage
and continuously perfused with OptiMEM medium supple-
mented with N2 growth complement (Invitrogen, Villebon sur
Yvette, France). Dynamic cell imaging was conducted using a
two-photon laser-scanning system (Trimscope; LaVision Biotec,
Bielefeld, Germany) in single-beam mode and a low-magnifica-
tion water-immersion objective (20X, NA 0.95 Plan Fluorite;
Olympus, New York, NY). A femtosecond pulsed laser (Ti:Sap-
phire; Coherent, Santa Clara, CA) provided wavelengths of 910
and970nmto excite eGFPandDsRed, respectively. Imageswere
captured using sensitive photomultiplier tubes and emission
filters of 510 and 593 nm for eGFP and DsRed, respectively.
Experiments were conducted for 12 h, and one z-stack, corre-
sponding to 20–50 images every 2 m along the z-axis, was
acquired every 5 min from the lateral zone of the gland, because
previous studies have demonstrated that sexually dimorphic al-
terations in GH-cell network function are most evident in this
portion of the pituitary (4). Cell motility was analyzed as pre-
viously described (23). The x, y, and z coordinates of individual
cells over time were obtained using Imaris Bitplane software
(Bitplane, Zurich, Switzerland).Motility and sphericity param-
eters were calculated using Imaris or MATLAB (MathWorks,
Natick, MA). The reported parameters include average speed
(defined as path length over time), instantaneous speed (path
length between two time points averaged over three successive
time points), and sphericity (1 a perfect sphere). Track lengths
were statically encoded using Imaris on a scale from 0 to 110m
to visually represent the path length of cells over a period of 4 h
of imaging, corresponding to a 4- to 8-h timeframe after eutha-
nasia for standardizationpurposes.Thex, y, and zdisplacements
of cells over a 4-h imaging period were plotted on three-dimen-
sional plots using Chaser script for MATLAB (23).
Clustering density analysis
Individual pituitary glands from intact, ovariectomized
(OVX) and OVX EE females were imaged using a Zeiss LSM
7MP multiphoton microscope (Zeiss, Oberkochen, Germany).
Volume/surface (V/S) ratios, an indicator of degree of GH-cell
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clustering, were calculated as previously described using a voxel
of 1024 1024 200mand the Imaris surface-rendering tool
(Bitplane) (4, 5).Using thismetric, a high ratio value corresponds
to a high level of cell clustering.
Calcium imaging
To investigate whether changes in GH-cell motility were ac-
companied by alterations in network activity over the time
course tested, calcium (Ca2) imaging was performed as previ-
ously described (4, 6). Briefly, 150-m-thickpituitary sliceswere
incubated for 1 h in a 20 M solution of fura 2-AM diluted with
a mixture of dimethylsulfoxide (0.01% wt/vol), 20% pluronic
acid (0.005%wt/vol) (all from Invitrogen), and Ringer solution
(125 mM NaCl, 2.5 mM KCl, 1.25 mM NaH2PO4, 26 mM
NaHCO3, 12 mM glucose, 2 mM CaCl2, and 1 mM MgCl2). For
all experiments, a 300  300 m area (2  2 binning) of the
pituitary gland was imaged using a two-photon system (Trim-
scope; LaVision Biotec) in 64-beam fast-scan mode. Wave-
lengths of 780 and 910 nmwere used to excite fura 2 and eGFP,
respectively. Images were captured with a 14-bit back-illumi-
nated EM-CCD camera (Andor, Belfast, Ireland) and emitted
signals recorded from 468 to 552 nm for both fluorophores.
Lambda scans were performed to ensure there was no overlap of
the emitted fluorescence signals. Experiments were conducted
for at least 30–60 min. During this time, slices were incubated
at 36C and continuously irrigatedwithRingers solution aerated
with 95%O2/5%CO2. GHRH 10 nM (Bachem, Munich, Ger-
many) was introduced through the perfusion system for the in-
dicated periods. After recording, GH-eGFP cells containing fura
2 were delineated with a region of interest and fluorescence over
time measurements obtained using ImageJ (National Institutes
of Health, Bethesda, MD). Since deflections in fura 2 emission
intensity correspond to rises in cytosolic Ca2 when imaged
above the isosbestic point, fluorescence emission signals were
inverted before normalization of Ca2 traces (F/Fmin). GHRH-
responsive cells were defined as those displaying a rapid and
sustained increase in intracellularCa2 concentrations of at least
20% above stable baseline levels. Ca2 traces were manipulated
and analyzed using custom algorithms programmed for Igor
Pro (Lake Oswego, OR) and MATLAB (freely available at
http://ipam.igf.cnrs.fr/).
Cell viability assay
To test cell viability in pituitary slices after 12 h of imaging,
ethidium homodimer-1 (EthD-1) staining was used (Sigma-Al-
drich, Saint-Quentin Fallavier, France). Cells with compromised
membranes exhibit red-fluorescence from the live-cell-imper-
meant nucleic acid stain EthD-1 (excitation 528 nm/emission
617 nm). Slices were incubated for 20 min at 37 C in Ringers
solution supplementedwith 2MEthD-1. Treatment for 30min
with 1% Triton X-100 (Sigma-Aldrich) was used to induce cell
death and determine maximum EthD-1 staining (as positive con-
trols). Sliceswere subsequently fixed in 4%paraformaldehyde and
imaged using aZeiss LSM510meta-confocal in single-trackmode.
Fluorescence-activated cell sorting analysis
Fresh pituitary glands were dissected immediately after eu-
thanasia, the neurointermediate lobe discarded, and anterior pi-
tuitary cells dispersed as previously described (3). Briefly, the
pituitary glands were preincubated for 10 min in 0.05% trypsin
before trituration and dispersion for 25 min in Hank’s Balanced
Salt Solution (pH 7.4) containing 50 caseinolytic U/ml dispase
(BD Bioscience, Marseilles, France), 2.25 mg/ml collagenase A,
and 25g/ml deoxyribonuclease (all from Sigma-Aldrich). Cells
were resuspended in 0.1 M PBS and flow cytometry performed
using aCoulter Epics XL-MCL flow cytometer (BeckmanCoulter,
Inc., Brea, CA). Data were analyzed with FlowJo software (Tree
Star, Ashland, OR).
Serum LH measurement
To confirm the gonadectomized status, uterine weights and
plasma LH concentrations were measured. Plasma LH values
were determined by specific RIA using reagents provided by the
National Institute of Diabetes and Digestive and Kidney Dis-
eases. Samples were assayed in triplicate and the limit of detec-
tion for LH was 0.2 ng/ml of plasma.
Statistical analysis
In all experiments, data normality was tested using the
D’Agostino and Pearson omnibus test. All displayed values
represent the mean  SEM from at least three independent
experiments.PairwisecomparisonsweremadeusingtheMann-
WhitneyU test.Multiple comparisonsweremade using one-way
ANOVA followed by Bonferroni’s post hoc test. P values were
considered significant at P  0.05, P  0.01, and P  0.001.
Results
Gonadectomy increases GH-cell motility in females
We performed overnight three-dimensional time-lapse
recordings of pituitary slices taken from postpubertal 60-
to 80-d-old male or female GH-eGFP mice. Different
groups of animals for each sex were used: sham, gonad-
ectomized (OVX or castration), and gonadectomized 
hormone replacement (OVX  EE in females). Uterine
weight and serum LH concentrations were measured as
confirmation of the effectiveness of OVX and subsequent
complementation with EE. As expected, a significant de-
crease in uterus weight could be observed inOVX females
(19 2mg vs. 121 21mg; OVX vs. sham, respectively;
P 0.05), which was reversed after EE complementation
(97 29mg, OVX EE, P 0.05 vs.OVX). LH plasma
levels were measured in the same conditions and, as ex-
pected, were significantly increased in the OVX animals
(39.0  5.0 ng/ml vs. 1.7  0.3 ng/ml, OVX vs. sham,
respectively, P 0.001) and suppressed in theOVX EE
group (0.6  0.1 ng/ml; P  0.001 vs. OVX).
Recordings of glands removed from intact male and
female animals revealed the presence of a quiescent GH-
cell network,whichdisplayedminimal structural turnover
as indicated by a homogeneous distribution of cell motil-
ities (Fig. 1andSupplementalVideos1and2,publishedon
TheEndocrine Society’s JournalsOnlineweb site at http://
endo.endojournals.org). Strikingly, 6 d after OVX, there
Endocrinology, December 2011, 152(12):4789–4799 endo.endojournals.org 4791
D
ow
nloaded from
 https://academ
ic.oup.com
/endo/article-abstract/152/12/4789/2457384 by guest on 28 April 2020
was a marked increase in GH-eGFP cell motility (Fig. 1
and Supplemental Video 3), which was not seen in OVX
females implantedwithEEpellets (SupplementalVideo4).
WhenGH-eGFP cellmotility ofOVX femaleswas directly
comparedwith that observed in intact animals, cells were,
on average, able to move over larger distances for a given
time period (Fig. 1A). This translated to a larger percent-
age of GH-eGFP cells displaying an average speed ofmore
than 6 m/h in OVX females vs. other states (0.8–1%
compared with 0.2–0.4%) (Fig. 1B). As shown by the
frequency distribution of the average speed of the most
motile cells (Fig. 1C), only a subset of GH-cells displayed
increased motility over the imaging period. In the other
conditions, cell speeds were low and clustered around the
FIG. 1. OVX induces an increase in GH-cell motility. A, Representative images of the GH-cell network in the lateral lobes of pituitary slices from
transgenic GH-eGFP male, female, OVX female, and OVX  EE complemented (OVX  EE) female animals acquired using a two-photon laser-
scanning system (Trimscope) in single-beam mode and a femto-pulsed laser tuned to 910 nm (top panels). Images correspond to the projection of
a 45-m z-stack (image dimensions, 250  250  45 m). The tracks followed by representative cells over a period of 4 h are represented for
each condition (bottom panels). Track lengths were statically color coded using Imaris (scale from 0 to 110 m). B, The average speed of the 20
most motile cells (n  5 independent animals for each condition) was calculated using Imaris. There was a significant increase in the percentage of
GH-cells moving over 6 m/h after OVX (one-way ANOVA; ***, P  0.001). Data represent mean  SEM. The total number of GH-cells within a
field was estimated by measuring the total GH-cell network volume in each z-stack image and the average volume of an individual GH-cell using
the surface rendering tool in Imaris. C, The relative frequency distribution of the average speed of the cells analyzed in B was significantly different
after OVX compared with the other conditions (n  5 animals, 20 cells/animal, one-way ANOVA; ***, P  0.001) and not homogenous. D,
Instantaneous speed of representative cells presenting the highest motility in each condition over the course of 4-h imaging time period (n  4
cells), showing the increase in average speed after OVX is actually due to peaks of instantaneous speed.
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same value, indicating that most cell movement was slow
and relatively homogeneous (Fig. 1C). Independent anal-
ysis of the instantaneous speeds of only cells displaying
increased motility after OVX (i.e. those with an average
speed of6m/h) revealed that cell displacementwas not
constant over time but showed spikes in instantaneous
speed of up to 5 m/min. This suggests that cellular reor-
ganization does not occur inOVX females bymeans of an
increase in average cell speed but rather occurs as large
individual steps between the start and end position (Fig.
1D). Large individual cell displacements after OVX were
not synchronized or accompanied by alterations to cell
shape, because the peaks of instantaneous speed were not
simultaneous between the different cells (Fig. 1D), and no
changes in sphericity could be detected (Fig. 2). Further-
more, cluster formation and dissociation could both be
observed in the time-lapsemovies afterOVX (Supplemen-
tal Videos 5 and 6, respectively). Suggesting that GH-cells
were not simply migrating out of the slice was the obser-
vation that cell movement did not possess a specific di-
rectionality (Fig. 3).
Changes in cell motility are not due to cell
death/hyperplasia
The changes in cellmotility observed afterOVXdidnot
reflect increased susceptibility of cells to phototoxicity, as
therewas very little uptakeofEthD into
nuclei after 12 h of imaging, demon-
strating good cell viability (Fig. 4A).
Moreover, increased motility was not
due to OVX-induced cell hypo/hyper-
plasia, because there was no significant
difference in the GH-cell content of pi-
tuitaries from sham and OVX animals
6 d after surgery (Fig. 4B).
Reciprocal alterations in cell
motility are not observed after
castration in males
Since testosterone has marked ef-
fects upon GH-network function and
output,we investigatedwhether castra-
tion in males would lead to similar (or
opposite) effects to those observed after
OVX in females. In intact animals,
there was no significant difference in
basal GH-cell motility between males
and females (average speed  SEM of
5.57 0.2 vs. 5.47 0.35m/h,males
vs. females, respectively; P  0.467)
(Fig. 1, A and B). More surprising was
the observation that the effects of go-
nadal steroids upon cell motility ap-
peared to be specific to females, because in males, cell
movement remained unchanged 6 d after castration (av-
erage speed, 5.47  0.35 vs. 6.25  0.25 m/h, male vs.
castrated, respectively; P  0.0571) (Fig. 5, A and B).
OVX influences GH-cell network architecture
To assess the contribution of OVX-induced cell motil-
ity to GH-cell network remodeling, we performed high
resolution imaging of GH-eGFP glands removed from in-
tact, OVX, andOVX EE females. GH-cell network V/S
ratios were significantly higher in OVX vs. intact females,
suggesting that OVXwas associated with a higher level of
GH-cell clustering (Fig. 6). Similarly to the changes in cell-
motility, this remodeling could be prevented by supple-
menting OVX animals with EE (Fig. 6).
Increased somatroph motility coincides with
modification of the GH-cell network response to
GHRH in females
By recording Ca2-signals emanating from the GH-
eGFP cell population in situ, wewere able to show that the
structural remodeling observed in response to OVX in
females was associated with heightened network function
(Fig. 7, A and B). Previous studies have shown that in
intact females, approximately 30% of GH-cells respond
FIG. 2. Bursts in GH-cell speed are not associated with major changes in cell shape. A, High-
magnification images of the GH-cell network in the lateral lobes of pituitary slices from a
transgenic GH-eGFP female 6 d OVX, acquired using a two-photon microscope as described
in Fig. 1. The two images were acquired at times 0 and 6.2 h, respectively, after initiation of
the imaging period (left panels). The positions of three representative cells (cells numbered
1–3) in images corresponding to projections along the z-axis are represented (left panels)
(image dimensions, 42  42  93 m). Green, GFP. The tracks followed by the same
representative cells over the imaging period are represented (right panel). Tracks were color
coded as a function of time using Imaris. Total track lengths were 68.9, 125.1, and 83.2 m
for cells 1, 2, and 3, respectively. B, Instantaneous speed (left panel) and sphericity (right
panel) of the three cells selected in A.
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coordinately to secretagogue, and this percentage in-
creases to 80%byd15afterOVX(4).Consistentwith this
was the observation that, 6 d after OVX in the current
study, almost 50% of GH-cells responded to GHRH by
firing coordinated Ca2 spikes (Fig. 7C).
Gonadal steroids do not affect lactotroph motility
We wondered whether OVX-induced motility was an
inherent property only of somatrophs or could be dem-
onstrated in other pituitary cell types (5). We chose to
study lactotrophs, sincewe had a similar fluorescent tag in
these cells. In addition, lactotrophs are known to be a
highly gonadal steroid-sensitive endocrine cell popula-
tion, in which proliferation, apoptosis, and function are
dramatically altered by estradiol levels (3, 24–27), and
they represent an abundant population in the female pi-
tuitary (28). Furthermore, PRL- andGH-cell networks are
tightly intermingled, so the reorganization of one cell net-
workmight also influence the other. However, in imaging
studies using pituitary slices from PRL-DsRed transgenic
mice, we observed no alterations in the motility of lac-
totrophs after OVX. PRL-DsRed cells displayed little dis-
placement over long periods of imaging (Fig. 8A), and the
average speed of even the most motile PRL-DsRed cells
from five independent experiments in PRL-DsRed OVX
females was not significantly different from that of GH-
eGFP cells in intact animals (Fig. 8B). Therefore, changes
in somatroph motility after OVX do not simply reflect an
increase in general motility of estradiol-sensitive pituitary
cells after gonadal steroid removal.
Discussion
To allow functional adaptation to changing environmen-
tal conditions, the pituitary gland has evolved to be a
highly plastic organ in mammals. Currently, the principal
mechanisms considered to underlie endocrine cell plastic-
ity in the pituitary are alterations in cell number and size.
However, in other organs, changes in cell movement rep-
resent a third mechanism, which contributes to tissue
plasticity (29). The pituitary gland has traditionally
been regarded as a rather static organ, but using mul-
tiphoton time-lapse imagingmethods,we clearly show the
existence of cell motility in the GH-cell population and
that it is altered during bouts of structural and functional
pituitary plasticity in females in response to changes in the
ovarian steroid milieu.
Previous studies by our group have
shown that after OVX in adult fe-
males, GH-cell network responses to
secretagogue administration are am-
plified and can be reversed with es-
tradiol (EE) replacement. By tracking
cell kinetics in real time, we were un-
able to see significant major changes
in GH-cell network structure over
timescales of a few hours in intact an-
imals. By contrast, 6 d after OVX in
females, there was a large and rapid
(minutes to hours) enhancement of
GH-cell motility, which was associ-
ated with GH-cell network remodel-
FIG. 3. Displacement of GH-cells does not present preferential
directionality. The x, y, and z coordinates of the 20 most motile cells (n
5 independent animals for each condition) were obtained using Imaris.
The x, y, and z displacement of cells over the 4-h imaging period was
plotted on three-dimensional plots using an open source algorithm for
MATLAB. The coordinate on each axis was set to 0 for each cell at t 0
of imaging period. Scales correspond to the20 to 20 m interval on
each axis.
FIG. 4. GH-cell network remodeling is not due to cell death or hyperplasia. A, Representative
confocal images of fixed, EthD-1 (red) stained slices from OVX GH-eGFP (green) females
immediately after euthanasia (left panel), after 12 h of imaging (middle panel), or after a 30-min
treatment with 1% Triton X-100 to induce cell death (right panel). No differential staining could
be observed before and after imaging nor between the different experimental conditions (male,
female, OVX, and OVX EE). Image dimensions, 230 230 10 m. B, Flow cytometry analysis
of the GH-cell content of whole pituitary glands from GH-eGFP female and OVX female animals
(n 4). At least 100,000 dispersed cells were analyzed. No significant difference (NS) could be
observed (Mann-Whitney test, P 0.05). Data represent mean SEM.
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ing as evidenced by increased GH-cell clustering. These
OVX-induced changes in GH-cell motility and network
remodeling could be prevented with prior EE supplemen-
tation and coincided with moderately enhanced GH-cell
network function in the formof coordinatedCa2-spiking
activity. As such, these data suggest that a reduction in E2
resulting fromOVXmaypromote rapid structural remod-
eling and enhanced cell-cell connectivity through a tran-
sient increase in cell motility, consistent with its effects on
GH-cell network connectivity and function (4). It should
be noted that no differences in basalGH-cellmotilitywere
detected between the sexes. Therefore, our findings reflect
a dynamic response to hormonal status and cannot be
related to normal patterns of GH secretion but rather
changes in network structure that then impact secretion.
Nevertheless, these data are consistent with in vivo
studies in rodents showing thatOVX leads to largermale-
likenocturnalGHpulses (30). Presumably, sexdifferences
in GH-cell network function (4, 5) are programmed
through either transient or prolonged increases in cell mo-
tility occurring around the time of sexual maturation and
do not require further changes in cell motility for main-
tenance of structural connectivity in adults.
The effects of estrogens on cell motility are well char-
acterized in other systems, with potent effects on tumor-
igenesis and metastasis. High doses of estradiol have been
shown to influence expression patterns of adhesion mol-
ecules and may alter cell-matrix inter-
actions, resulting in lossof cell adhesion
(31). An increase in actin remodeling
may also lead to formation of mem-
brane structures, which favor cell mi-
gration (32). The mechanisms underly-
ing the increased GH-cell motility after
OVX and estradiol withdrawal remain
unknown. However, previous studies
have shown that estradiol inhibits the
invasive potential of some ovarian can-
cer cell lines (33, 34) and prevents pros-
taglandin E2-induced cellular motility
of human colon cancer cells (35). Since
there are specific cadherin expression
patterns in pituitary GH-cells (36), it is
reasonable to speculate that estradiol
withdrawal may directly or indirectly
alter these to promote an increase in
GH-cell motility.
The increase we observed in cell mo-
tility after OVX was relatively specific
forGH-cells and thus unlikely to be due
to a generalized nonspecific effect of es-
tradiol such as induction of cell death/
fragility or hyperplasia (because the GH-cell content was
comparable in intact and OVX females). Although OVX
may have conceivably resulted in an increase in GH-cell
proliferation rate, which was balanced by an increase in
cell death, leading to enhanced cell motility and structural
remodeling, available evidence suggests otherwise: estra-
diol tends to sensitize pituitary cells to proapoptotic and
mitogenic signals (27, 37), the GH-cell population is re-
markably stable (i.e. there is no trans-differentiation into
mammo-GH-cells) during periods of high estradiol con-
centrations in mice (3), and only approximately 3% of
GH-cells in female rodents are immunoreactive for ER,
the membrane receptor subtype predominantly expressed
in the anterior pituitary and which is implicated in rapid
apoptotic effects of estradiol (38–40). It cannot be ex-
cluded that a change in GH-cell kinetics observed after
OVX might be secondary to similar changes in other net-
works.Webelievewe can rule out thePRL-network, as the
neighboring lactotrophs remained static under the same
conditions. Another obvious population, although much
smaller in number, would be pituitary gonadotrophs,
whose activity and potential mobility might well be ex-
pected to increase in response to the gonadectomy-in-
duced GnRH surge (41). If so, it might also be expected to
alter somatotroph motility in males, but such changes
were not observed.Nevertheless, animalswith taggedLH/
FSH-secreting cells have recently become available (42,
FIG. 5. Gonadectomy in males does not induce changes in GH-cell motility. A, Representative
images of the GH-cell network in the lateral lobes of pituitary slices from transgenic GH-eGFP
male and castrated (Cast) male animals acquired using a two-photon microscope as described
in Fig. 1 (top panels). Images correspond to the projection of a 45-m z-stack (image dimensions,
250 250 45 m). The tracks followed by representative cells over a period of 4 h are
represented for each condition (bottom panels). Track lengths were statically color coded using
Imaris (scale from 0 to 110 m). B, The average speed of the 20 most motile cells (n 3–5
independent animals for each condition) were calculated using Imaris. No significant difference
(NS) could be observed (Mann-Whitney test, P 0.05). Data represent mean SEM.
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43), so it could be interesting to directly study gonado-
troph motility. Other possible indirect effects could in-
clude vascular or folliculostellate cell remodeling (44), but
again, there is no evidence suggesting that this would be
relatively cell and/or sex specific. We prefer the simpler
hypothesis that motility in the GH-cell network contrib-
utes to the gonadal-sensitive structural and functional
plasticity that we have previously demonstrated in female
mice (4).
Only a subpopulation ofGH-cells could be shown tobe
involved in network remodeling events over our imaging
period, indicating that cells comprising the GH-cell net-
work are differentially responsive to OVX. There are a
number of nonmutually exclusive explanations for this
observation. First, OVX may only be able to activate in-
tracellular pathways involved in cell migration in a subset
of cells due to the aforementioned low levels of ER ex-
pression by somatrophs. Second, studies using estradiol-
deficient aromatase knockout mice implicate estrogens in
the normal expression of GHRH receptors, which would
conferGH-cell specificity (45).UnderexpressionofGHRHre-
ceptors restricted to a subpopulation of ER-expressing
GH-cells could lead to loss of situational awareness. In-
deed, GHRH signaling is essential for cell proper place-
ment within the GH-cell network during development,
because animals deficient in GHRH suffer severe GH-cell
hypoplasia and a loss of cell clustering (46). Equally plau-
sible is a GH-cell-specific role for estrogens in regulat-
ing the balance between GHRH and somatostatin
receptors. Somatostatin has long been known to restrain
GH-cell activity (47), so it is possible that somatostatin
receptors may also be involved in restraining cell motility,
and reducing their expression by removing endogenous
estrogens would lessen this effect (48). Third, OVX may
result in regional changes in chemo-attractant concentra-
tions through changes in the paracrine output of neigh-
boring estrogen-sensitive cell types, such as lactotrophs
(49, 50). Fourth, remodelingmayprogressively occur over
several days, so we may not capture the full extent of
GH-cell motility using the current methods. Together,
thesemechanismswould account for the restriction of cell
motility to only 1% of the imaged GH-cell network and
provide a potential explanation formovement of bothER-
and non-ER-expressing GH-cells.
The large change in GH-cell network function (20%)
may not only be associated with an increase in motility of
a small proportion (1%) of GH-cells. Since animals were
OVX on d 1 and experiments conducted for a 12-h win-
dow on d 6, a higher proportion of cells may have moved
before the recording period but subsequently become im-
motile. This is supported by the fact that large individual
FIG. 6. OVX induces GH-cell network remodeling in females. Effect of
OVX and OVX  hormone replacement on the V/S ratio of the GH-cell
network in female GH-eGFP mice. A significant increase in the V/S
ratio was observed after OVX. These changes in V/S are prevented if
animals are supplemented with EE at the time of OVX (6–10 surface
rendering of high-resolution images of the GH-cell network of
dimension 1024  1024  200 m were used for each group, one-
way ANOVA; **, P  0.01 and ***, P  0.001). Data represent
mean  SEM).
FIG. 7. Increased GH-cell motility coincides with modification of GH-
cell network response in females. A, Calcium (Ca2) imaging was
performed using a two-photon microscope in multiplexed (64 beam)
mode and a laser tuned to 780 nm (field 300  300 m, 100
imaged cells; 2  2 binning). Acute pituitary slice preparations from
intact GH-eGFP females were prepared and loaded with the Ca2-
sensor, fura 2. GHRH (10 nM) was perfused onto the slice for the
indicated time period. GH-eGFP cells coloaded with fura 2 were
postidentified in ImageJ with a region of interest and intensity over
time measurements plotted (a.u.  arbitary intensity units). Note that
in intact animals, cells responded to GHRH input by firing highly
coordinated Ca2 spikes. B, As for A but from pituitary slices obtained
from OVX females. A greater proportion of cells responded to
application of the same dose of GHRH. C, The number of cells that
coordinately respond to GHRH application was significantly higher 6 d
after OVX (n  7 slices from four animals for each condition, Mann-
Whitney test; **, P  0.01). Data represent mean  SEM.
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cell displacements after OVX were rarely synchronized
and that high-resolution imaging of GH-eGFP glands
demonstrated a dramatic effect of OVX on GH-cell net-
work remodeling in termsofGH-cell clustering,which can
be blocked byEE.Wehave previously shown thatGH-cell
clustering is an important indicator of connectivity as de-
termined by measurement of coordinated cell activity (4,
5). It is also possible that because correlated activity in the
GH-cell network is dictatedbya small numberofGH-cells
(4–6), a change in motility of a small proportion of cells
could conceivably result in the connectivity required to
produce such correlation patterns.
Although acute pituitary slice preparations were im-
aged ex vivo, outside of the influence of hypothalamic
stimulation,we cannot fully exclude that the increased cell
motility observed in OVX females was due to effects of
estrogens at the level of GHRH neurons. Indeed, changes
in cell motility could have been preprogrammed through
chronic changes in estrogen-responsive GHRH input to
the pituitary gland over the 6-d period afterOVX. Further
experiments involving in vivo ablation of GHRHneurons
in adult OVX EE animals would be required to further
delineate this, as simply applying exogenous estradiol to
slices taken from OVX animals would not reflect the
chronic nature of the treatment paradigms used.
Supporting a role for estradiol and not testosterone in
GH-cell motility was the observation that the GH-cell
population remained static over the recording period in
gonadectomizedmales.Therefore, previous reports show-
ing that castration attenuates GH-cell network function
(4) may reflect activational effects of testosterone on GH-
cell secretory activity. The mechanisms by which testos-
terone promotesGH-cell function and output inmales are
not well defined, although it could involve permissive ef-
fects of androgens on GH-cell proliferation, GH-cell se-
cretory capacity, and pituitary ghrelin content, a potent
GH secretagogue (51–54).
Similar live-imaging studies of both dispersed cells and
acute slice preparations have demonstrated that pituitary
gonadotrophs extend processes and spatially reposition
themselves toward blood vessels in response to exogenous
GnRH application (41). Furthermore, static confocal
studies have provided evidence that both gonadotrophs
and corticotrophs contact vessels during periods of peak
secretory demand (55, 56). Therefore, cell motility ap-
pears to be an intrinsic property of cell populations com-
prising the mammalian pituitary gland. In the present
study, we were unable to detect obvious changes in cell
morphology, such as formation of pseudopods/extension
of processes. However, this may be a consequence of the
spatial (axial resolution of 1.41 m; z-step 2 m) and
temporal resolutions (one acquisition every 5 min),
which may be insufficient to detect cytoskeletal
changes. Further studies using higher magnification/
higher numerical aperture objectives and faster acqui-
sition rates would be required to clarify this issue.
In conclusion, by using time-lapsemicroscopy to image
acute pituitary slices prepared from GH-eGFP mice, we
provide evidence thatGH-cellsmove and that thismotility
is acutely and transiently enhanced by OVX in mice. This
could directly contribute to the ability of estrogens to
remodel the GH-cell network both structurally and func-
tionally. Our data provide new insights into the mecha-
nismsunderlying estrogen-inducedplasticity at the level of
the pituitary gland.
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